Logo

Agilent Obtains Abbott License to Make, Sell Microarrays for Expression, CGH Apps

Aug 30, 2006
NEW YORK (GenomeWeb News) – Agilent today said Abbott Molecular has granted it a license to manufacture, market, and sell oligonucleotide microarrays using a two-or-more color technology for gene expression and comparative genomic hybridization applications.

The worldwide, non-exclusive license covers the use of microarrays for research, commercial labs, and in vitro diagnostic applications.

 
Financial details were not disclosed.

Filed under

Microarrays & Multiplexing
microarrays
Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.